Invivoscribe logo

Invivoscribe

Improving Lives with Precision Diagnostics®

199 employees · est. 1995 · San Diego, United States

VS
WuXi Diagnostics logo

WuXi Diagnostics

A next-generation integrated diagnostic enabling platform

46 employees · est. 2018 · Shanghai, China

Invivoscribe is the older company (1995 vs 2018); Invivoscribe is the larger of the two.

Side-by-Side Comparison

Invivoscribe WuXi Diagnostics
Founded
1995 older 2018
Headquarters
San Diego, United States Shanghai, China
Employees
199 larger 46
Industry
Biotechnology, Health Care Biotechnology, Health Care, Medical Devices
Funding Stage
Not tracked yet Series B
Total Funding
Not tracked yet $150.00M
Funding Rounds
Not tracked yet 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Precision Diagnostics, Oncology, Companion Diagnostics, Therapeutics, CGMP Facility, Clonal Gene Rearrangements, Gene Mutation Testing, Measurable Residual Disease, Molecular Testing, Precision Medicine, Biopharma Services, Clinical Diagnostics, Flow Cytometry, Global Healthcare Integrated Diagnostic, Diagnostic Platform, R&D Center, In Vitro Diagnostic, Clinical Laboratory, Precision Diagnosis, Medical Innovation, Disease Management, Diagnostic Solutions, Multidisciplinary Technology, Clinical Evidence, Medical Algorithms, Medical Content, Healthcare Ecosystem
Website
invivoscribe.com wuxidiagnostics.com
Invivoscribe logo

About Invivoscribe

Invivoscribe® is a global leader in the biotechnology and healthcare industries, founded in 1995 with its headquarters in the United States. The company is dedicated to Improving Lives with Precision Diagnostics® and focuses on advancing the quality of healthcare through its innovative products and...

WuXi Diagnostics logo

About WuXi Diagnostics

WuXi Diagnostics (WXDX) is a groundbreaking biotechnology company founded in 2018 with a vision to revolutionize healthcare through its next-generation integrated diagnostic enabling platform. With headquarters in Shanghai, China, it boasts a CAP-accredited Independent Clinical Laboratory and a prod...

We will tell you when either one moves

BounceWatch watches Invivoscribe and WuXi Diagnostics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Invivoscribe and WuXi Diagnostics — by email.

Frequently Asked Questions

Invivoscribe — Improving Lives with Precision Diagnostics®. WuXi Diagnostics — A next-generation integrated diagnostic enabling platform. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Invivoscribe has raised undisclosed funding while WuXi Diagnostics has raised $150.00M.
Invivoscribe and WuXi Diagnostics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Invivoscribe with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Invivoscribe on 12 Sep 2024, and WuXi Diagnostics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy